Ana Paula Tagliari

🎙️Professor @azeemlatib shared his perspective on the future of valve therapy, discussing what could be the next groundbreaking innovation in treating the 3️⃣ heart valves: #aortic, #mitral, and #tricuspid ⤵️ @PCRonline

PCI for complex bifurcation disease 📺pcronline.com/Cases-resource… Watch the replay of this LIVE educational case to learn more about 🟣 stepwise provisional strategy 🟣the application of intravascular imaging during bifurcation interventions 🟣the role of drug-coated…

Guess what’s still missing from #PCRLV? 👉Your submissions! Send in your Scientific Abstracts, Clinical Cases, Innovations and Late-Breaking Trials by 2 September 📩 🗓️PCR London Valves | 16-18 November pcronline.com/Courses/PCR-Lo…

📌 HALT after TAVI: variable response to DOACs This case-based report highlights haemodynamic valve deterioration (HVD) linked to HALT, with heterogeneous outcomes to DOAC therapy. Warfarin may be more effective in selected cases. @AliSahebHusain ow.ly/Kltr50WuFhU #TAVI…

Here we go! 🎧 Congratulations to @EuroInterventio on the launch of Turning Point, a podcast series celebrating 2️⃣0️⃣ years of excellence in coronary, valvular and structural interventions! And special thanks 🙏🏼 to @aayshacader for “lending” us her voice as podcast host

Unusual coronary complications shared by your peers 🔗pcronline.com/Cases-resource… (access via your free My PCR account) Take a closer look at these rare coronary mishaps and the smart techniques that helped salvage the situation: trapped tools, ruptured balloons, and more.…

The first case in the ARTIST Trial is complete! JenaValve announces the first completed case in the ARTIST Trial, a pivotal study comparing the Trilogy Heart Valve to surgery in patients at low or intermediate surgical risk. Read the full press release to learn more:…

A real honor to direct this #CLIMB2025 with @carlaagatiello1 and @MayraGuerreroMD focused on structural cardiac interventions starting with TAVI 🔝lectures with a vision to the future and how to set up your program to treat #AS @WomenAs1 @DeeDeeWangMD @iCorGTrias @GTRecerca

New findings presented at #NYValves2025 by @GilbertTangMD found that MitraClip was safe and effective for those who did not meet the criteria for the COAPT study. This could potentially make M-TEER an option for certain patients with secondary MR and advanced heart disease.…

Artificial intelligence (AI) has emerging applications in cardiovascular pharmacotherapy, including treatment selection, prediction of outcomes, and trial optimization. Our manuscript reviews current AI uses in therapy, trials, and drug discovery. academic.oup.com/eurheartj/adva…

Four-year follow-up data from this multicentre study of the balloon-expandable Myval TAVI system report valve-related outcomes including haemodynamic deterioration, bioprosthetic valve failure, and patient–prosthesis mismatch, as defined by VARC-3. eurointervention.pcronline.com/article/four-y… #TAVI…

Thread: MITRO-AORTIC CURTAIN Anatomically mitro-aortic curtain is membranous tissue between the aortic valve and anterior mitral leaflet. It extends between nadir of non-coronary and left cusps and continues in AML.

🚨Early Fee deadline for #PCRLV 2025 📍Last chance to register at the lowest rate! ## Secure your spot now ## 🗓️16-18 November 2025 @PCRonline

Officially launched @WomenAsOne CLIMB SHD track 2025! And bilingual 🙂Thank you to WomenAsOne, all the speakers and attendees! 🙏I can’t wait to the next session! @CarlaAgatiello @VDelgadoGarcia @DeeDeeWangMD @DebbieNercolini @MayoClinicCV

Can’t wait for this new podcast 🎧 series! Episode 1️⃣ will trace back the history of @EuroInterventio & personal story of Patrick Serruys, the first Editor in Chief of your favourite #InterventionalCardiology Journal, interviewed by @aayshacader #20YearsOfEuroIntervention

DON’T FORGET your most interesting surgical case to @JACCJournals #JACCCaseReports! You don’t have to be a surgeon to submit as long as you include them on your author group. We would love to see fascinating Intraop images, videos and techniques, and pathology and histology too!…

In the randomized, open-label AUREA trial, an OAC strategy for 3 months post-TAVI did not show any benefit over an antiplatelet strategy in preventing cerebral microembolism in patients without an indication for OAC. Patients treated with DAPT showed a lower mean volume of brain…

State-of-the-art in @EuroInterventio Comprehensive review on bioprosthetic valve dysfunction after TAVI: mechanisms, diagnosis, and management. Midterm BVF incidence remains low (<5%), with SVD as the key driver. Durability appears comparable to SAVR. @TernacleJ @PPibarot…

What an unforgettable #NYValves2025! 🎉 With over 3,000 attendees from around the world, this year’s meeting was a celebration of innovation, collaboration, and cutting-edge science in structural heart care. 🫀✨ A huge thank you to our faculty, attendees, and supporters for…

Important finding on CT and fluoro showing 2nd TAV in Redo #TAVR were 100% underexpanded despite procedural optimization with pre and post dilatation. Time to rethink lifetime management strategy and consider #TAVR explant in low risk pts to avoid redo TAVR PPM ? @JACCJournals…

M-TEER for challenging anatomies 📺pcronline.com/Cases-resource… (watch replay with your free My PCR acount) Learn how to manage challenging anatomies in mitral TEER (small left atria, large coaptation gaps, giant left atria) and the risks they pose. Build confidence in…